Literature DB >> 9952196

Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.

J A Papadakis, D P Mikhailidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9952196

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.

Authors:  Eric A Collisson; Celina Kleer; Mei Wu; Abhijit De; Sanjiv S Gambhir; Sofia D Merajver; Michael S Kolodney
Journal:  Mol Cancer Ther       Date:  2003-10       Impact factor: 6.261

Review 2.  Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy.

Authors:  Józef Dulak; Alicja Józkowicz
Journal:  Curr Cancer Drug Targets       Date:  2005-12       Impact factor: 3.428
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.